| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |